Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boeing Co (BA) vs Zoetis Inc (ZTS) Price & Performance

Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Boeing Co vs Zoetis Inc — how do they compare? Boeing Co trades at $234 (market cap $184.35B), while Zoetis Inc trades at $74.9 (market cap $31.14B). The key difference: Boeing Co is far larger — about 5.9× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.

BAZTS
Market Cap
$184.35B$31.14B
Volume
7,591,579
Sector
IndustrialsHealth
52-Week High
$252.15$156.76
52-Week Low
$179.12$71.91
Enterprise Value
$210.23B$38.70B
Dividend Yield
0.03%2.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boeing Co

Boeing (BA) trades at $232.79, down 0.7% on the day, with a bullish technical signal supported by moving averages. The company reported revenue of $89.46B in 2025, swinging to a net income of $2.24B, and recent news highlights its strategic sale of non-core aviation technology units to Archer Aviation to sharpen focus on core aerospace and defense operations.

The outlook is positive with a consensus price target of $280.83, though high valuation ratios and volatile cash flows pose risks. Earnings momentum is mixed, with a recent Q2 2026 EPS miss, but analyst sentiment remains strongly bullish with 67% buy ratings.

Zoetis Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boeing Co

The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.

Read more on BA

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS